https://investors.apotex.com/ Explore Apotex Investor Relations, including financial performance, stock data, annual reports, and latest corporate news. https://investors.apotex.com/2026-07-16-Apotex-Receives-Investment-Grade-Issuer-Rating-from-Morningstar-DBRS-and-Announces-Amended-Restated-Credit-Agreement Thu, 16 Jul 2026 10:40:00 -0400 https://investors.apotex.com/2026-07-16-Apotex-Receives-Investment-Grade-Issuer-Rating-from-Morningstar-DBRS-and-Announces-Amended-Restated-Credit-Agreement https://investors.apotex.com/2026-07-09-Apotex-to-Announce-First-Quarter-Fiscal-2027-Financial-Results-and-Host-Conference-Call-on-August-12,-2026 Thu, 09 Jul 2026 11:51:00 -0400 https://investors.apotex.com/2026-07-09-Apotex-to-Announce-First-Quarter-Fiscal-2027-Financial-Results-and-Host-Conference-Call-on-August-12,-2026 https://investors.apotex.com/2026-07-08-Apotex-expands-U-S-hospital-portfolio-with-launch-of-generic-Infuvite-R-Adult-and-Pediatric-Injection Wed, 08 Jul 2026 09:00:00 -0400 https://investors.apotex.com/2026-07-08-Apotex-expands-U-S-hospital-portfolio-with-launch-of-generic-Infuvite-R-Adult-and-Pediatric-Injection https://investors.apotex.com/2026-07-01-Apotex-Completes-Previously-Announced-Strategic-Transaction-with-Cumberland-Pharmaceuticals Wed, 01 Jul 2026 09:00:00 -0400 https://investors.apotex.com/2026-07-01-Apotex-Completes-Previously-Announced-Strategic-Transaction-with-Cumberland-Pharmaceuticals https://investors.apotex.com/2026-06-30-Apotex-first-to-receive-Health-Canada-approval-for-SEVMIA-TM-,-a-generic-semaglutide-for-chronic-weight-management Tue, 30 Jun 2026 16:19:00 -0400 https://investors.apotex.com/2026-06-30-Apotex-first-to-receive-Health-Canada-approval-for-SEVMIA-TM-,-a-generic-semaglutide-for-chronic-weight-management